Myocardial infarction with non-obstructive coronary artery in a middle-aged woman with COVID-19
Amir Farhang Zand Parsa1, Hamidreza Pouraliakbar2, Zahra Raisi-Estabragh3
1Department of Cardiology, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
Insights
This case study highlights a patient with COVID-19 pneumonia who developed acute heart failure and myocardial infarction, despite no prior cardiovascular risk factors. It underscores the potential for severe cardiac complications from COVID-19.
Area of Science:
- Cardiology
- Infectious Diseases
- Critical Care Medicine
Background:
- Cardiovascular involvement is a known complication of coronavirus disease 2019 (COVID-19).
- COVID-19 can precipitate de novo cardiac conditions such as myocarditis and myocardial infarction.
- The pandemic led to reduced admissions for acute coronary syndromes due to patient reluctance to seek care.
Observation:
- A 47-year-old woman presented with acute heart failure and COVID-19 pneumonia.
- She reported chest pain two weeks prior but had no traditional coronary risk factors.
- Electrocardiogram suggested late-presenting myocardial infarction, and echocardiography revealed severe left ventricular systolic dysfunction.
Findings:
- Coronary angiography revealed no significant flow-limiting lesions.
- Cardiac magnetic resonance imaging demonstrated subendocardial enhancement in the left anterior descending artery territory.
- These findings were compatible with myocardial infarction.
Implications:
- This case illustrates that COVID-19 can cause myocardial infarction even in individuals without pre-existing cardiovascular risk factors.
- It emphasizes the importance of considering cardiac complications in COVID-19 patients presenting with heart failure symptoms.
- Prompt diagnosis and management are crucial for improving outcomes in these patients.
Abstract:
Cardiovascular involvement is commonly described in coronavirus disease 2019 (COVID-19), where myocardial injury can be caused by exacerbation of the underlying disease and de novo cardiovascular involvement, including myocarditis, stress cardiomyopathy and myocardial infarction. There was a drop in acute coronary syndrome admission rates worldwide as collateral damage of the COVID-19 pandemic as patients were reluctant to seek appropriate care. We presented a 47-year-old woman with acute heart failure and COVID-19 pneumonia. She had a history of typical prolonged chest pain 2 weeks before but no coronary risk factors. The electrocardiogram was consistent with late presentation myocardial infarction. Focused echocardiography showed severe left ventricle systolic dysfunction. She was medically treated for both pneumonia and heart failure. Coronary angiography showed no flow-limiting lesion. Cardiac magnetic resonance in the recovery phase revealed subendocardial late gadolinium enhancement in the left anterior descending territory compatible with myocardial infarction.
More Related Videos
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Coronary Artery Disease III: Clinical Manifestations
Myocarditis III: Medical Management
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Coronary Artery Disease II: Pathophysiology
Acute Coronary Syndrome III: Diagnostic Studies


